gabapentin has been researched along with mibefradil in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Back, SK; Choo, HY; Kam, YL; Na, HS; Rhee, HK; Rhim, H | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chung, HJ; Lee, YS; Pae, AN; Roh, EJ; Seo, SH; Shin, KJ; Song, CM; Woo, HM | 1 |
| Chung, H; Keum, G; Kim, JH; Nam, G | 1 |
| Kim, JH; Nam, G | 1 |
| Jeong, KS; Lim, SM; Pae, AN; Son, WS | 1 |
10 other study(ies) available for gabapentin and mibefradil
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Synthesis and T-type calcium channel blocking activity of novel diphenylpiperazine compounds, and evaluation of in vivo analgesic activity.
Topics: Analgesics; Animals; Calcium Channels, T-Type; Humans; Neuralgia; Pain Measurement; Piperazines; Rats | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Hyperalgesia; Inhibitory Concentration 50; Ligands; Mibefradil; Molecular Structure; Molecular Targeted Therapy; Neuralgia; Patch-Clamp Techniques; Piperidines; Quantitative Structure-Activity Relationship; Rats; Spinal Nerves; Structure-Activity Relationship | 2011 |
Synthesis and T-type calcium channel-blocking effects of aryl(1,5-disubstituted-pyrazol-3-yl)methyl sulfonamides for neuropathic pain treatment.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Chemistry Techniques, Synthetic; Drug Stability; Humans; Neuralgia; Rats; Sulfonamides | 2016 |
Synthesis and evaluation of 6-pyrazoylamido-3N-substituted azabicyclo[3,1,0]hexane derivatives as T-type calcium channel inhibitors for treatment of neuropathic pain.
Topics: Administration, Oral; Animals; Azabicyclo Compounds; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; HEK293 Cells; Humans; Male; Neuralgia; Pyrazoles; Rats; Structure-Activity Relationship | 2016 |
Structural hybridization of pyrrolidine-based T-type calcium channel inhibitors and exploration of their analgesic effects in a neuropathic pain model.
Topics: Analgesics; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Calcium Signaling; Disease Models, Animal; Gabapentin; Ganglia, Spinal; Humans; Ligation; Microsomes, Liver; Molecular Structure; Neuralgia; Pyrrolidines; Rats; Structure-Activity Relationship | 2019 |